Cutibacterium avidum antibiotic resistance bone and joint infections in vivo emergence of resistance mechanisms of resistance osteoarticular infection

Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
17 08 2023
Historique:
medline: 21 8 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: ppublish

Résumé

Cutibacterium avidum is an emerging causative agent of orthopedic device-related infections (ODRIs). There are no guidelines for the antimicrobial treatment of

Identifiants

pubmed: 37289061
doi: 10.1128/spectrum.03687-22
pmc: PMC10434181
doi:

Substances chimiques

Levofloxacin 6GNT3Y5LMF
Rifampin VJT6J7R4TR
Anti-Bacterial Agents 0
Fluoroquinolones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0368722

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Nucleic Acids Res. 2017 Jan 4;45(D1):D535-D542
pubmed: 27899627
Br J Dermatol. 2020 Jul;183(1):105-113
pubmed: 31610037
Anaerobe. 2016 Dec;42:166-171
pubmed: 27793740
Clin Microbiol Infect. 2011 Mar;17(3):447-50
pubmed: 20825439
Eur J Clin Microbiol Infect Dis. 2020 Jul;39(7):1357-1364
pubmed: 32125556
Cell. 2001 Mar 23;104(6):901-12
pubmed: 11290327
PLoS One. 2016 Jun 29;11(6):e0158164
pubmed: 27355425
Antimicrob Agents Chemother. 1998 Oct;42(10):2590-4
pubmed: 9756760
Clin Infect Dis. 2018 Jan 6;66(1):54-63
pubmed: 29020266
Anaerobe. 2017 Oct;47:194-200
pubmed: 28602804
Antimicrob Agents Chemother. 1998 Feb;42(2):236-40
pubmed: 9527766
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Clin Microbiol Rev. 2018 May 30;31(3):
pubmed: 29848774
J Bacteriol. 1990 Dec;172(12):7260-2
pubmed: 2174869
Biochemistry. 1989 May 2;28(9):3886-94
pubmed: 2546585
J Antimicrob Chemother. 2013 Mar;68(3):523-8
pubmed: 23115111
Evol Appl. 2015 Mar;8(3):273-83
pubmed: 25861385
PeerJ. 2017 Aug 30;5:e3720
pubmed: 28875074
Nat Biotechnol. 2013 Apr;31(4):294-6
pubmed: 23563421
J Arthroplasty. 2018 Jul;33(7):2246-2250
pubmed: 29544969
Antimicrob Agents Chemother. 2011 May;55(5):1946-52
pubmed: 21357297

Auteurs

Scott A Cunningham (SA)

Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Christophe Rodriguez (C)

NGS Platform, IMRB, CHU Henri Mondor, Créteil, France.
Institut Mondor de Recherche Biomédicale, Inserm U955, Créteil, France.

Paul-Louis Woerther (PL)

NGS Platform, IMRB, CHU Henri Mondor, Créteil, France.
Institut Mondor de Recherche Biomédicale, Inserm U955, Créteil, France.

Christophe Menigaux (C)

APHP, GHU Paris Saclay, Hôpital Ambroise Paré, Orthopedic Surgery Department, Boulogne-Billancourt, France.

Thomas Bauer (T)

APHP, GHU Paris Saclay, Hôpital Ambroise Paré, Orthopedic Surgery Department, Boulogne-Billancourt, France.

Jean-Louis Herrmann (JL)

APHP, GHU Paris Saclay, Hôpital Raymond Poincaré, Microbiology Department, Garches, France.
Université Paris-Saclay, UVSQ, Inserm, Infection et Inflammation, Montigny-Le-Bretonneux, France.

Martin Rottman (M)

APHP, GHU Paris Saclay, Hôpital Raymond Poincaré, Microbiology Department, Garches, France.
Université Paris-Saclay, UVSQ, Inserm, Infection et Inflammation, Montigny-Le-Bretonneux, France.

Anne-Laure Roux (AL)

Université Paris-Saclay, UVSQ, Inserm, Infection et Inflammation, Montigny-Le-Bretonneux, France.
APHP, GHU Paris Saclay, Hôpital Ambroise Paré, Microbiology Department, Boulogne-Billancourt, France.

Jean-Louis Gaillard (JL)

Université Paris-Saclay, UVSQ, Inserm, Infection et Inflammation, Montigny-Le-Bretonneux, France.
APHP, GHU Paris Saclay, Hôpital Ambroise Paré, Microbiology Department, Boulogne-Billancourt, France.

Robin Patel (R)

Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Faten El Sayed (F)

Université Paris-Saclay, UVSQ, Inserm, Infection et Inflammation, Montigny-Le-Bretonneux, France.
APHP, GHU Paris Saclay, Hôpital Ambroise Paré, Microbiology Department, Boulogne-Billancourt, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH